Samuel Tromans
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Samuel Tromans has a total of 242 co-authors. Here are the top co-authors by number of shared publications:
- Rohit Shankar
Peninsula School of Medicine, University of Plymouth, Truro, UK
21 shared publications - Regi Tharian Alexander
Hertfordshire Partnership NHS Foundation Trust
10 shared publications - Ashok Roy
Coventry and Warwickshire Partnership NHS Trust
9 shared publications Indermeet Sawhney
Hertfordshire Partnership University NHS Foundation Trust
9 shared publications- Richard Laugharne
Cornwall Partnership NHS Foundation Trust
9 shared publications - Verity Chester
Hertfordshire Partnership University NHS Foundation Trust , Radlett
7 shared publications
Latest Publications
- 3 November 2026
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- p. 1-4
Learning from deaths to improve lives: why England still needs a national LeDeR programme
Summary: The National Health Service England’s Learning from Lives and Deaths of People with a Learning Disability and Autistic People programme is the world’s only national mortality review system for people with intellectual disability. Abandoning national mortality surveillance risks making preventable deaths less visible, with profound consequences for equity in healthcare.
- 3 November 2026
- Published by Royal College of Psychiatrists in The British Journal of Psychiatry
- p. 1-4
Learning from deaths to improve lives: why England still needs a national LeDeR programme
Summary: The National Health Service England’s Learning from Lives and Deaths of People with a Learning Disability and Autistic People programme is the world’s only national mortality review system for people with intellectual disability. Abandoning national mortality surveillance risks making preventable deaths less visible, with profound consequences for equity in healthcare.
- 21 October 2026
- Published by Emerald Publishing in Equality, Diversity and Inclusion: An International Journal
- p. 1-18
Accessing reasonable adjustments in UK policing: exploring the lived experiences of autistic officers and staff and those with ADHD
Purpose: This study examines the experiences of autistic police officers and staff and those with attention deficit hyperactivity disorder (ADHD) in accessing and utilising reasonable adjustments. Design/methodology/approach: We conducted reflective interviews with 37 UK autistic officers and staff and those with ADHD. Findings: Reflexive thematic analysis identified three themes: (1) identifying and requesting adjustments, (2) rank-based hierarchies and the role of gatekeepers and (3) navigating police process. Practical implications: Results suggest urgent need for training, streamlined adjustment processes, collaborative approaches to identifying needs and broader cultural transformation towards genuine neuro-inclusivity in policing organisations. Originality/value: Research with this population is rare but deserves attention. Policing is imbued with rank-based hierarchies, and findings showed how participants situated adjustments requests within this framing. Organisational features of policing are reflected in protocols and processes which were perceived as burdensome and created fears that their label may be weaponised against them.
- 21 October 2026
- Published by Emerald Publishing in Equality, Diversity and Inclusion: An International Journal
- p. 1-18
Accessing reasonable adjustments in UK policing: exploring the lived experiences of autistic officers and staff and those with ADHD
Purpose: This study examines the experiences of autistic police officers and staff and those with attention deficit hyperactivity disorder (ADHD) in accessing and utilising reasonable adjustments. Design/methodology/approach: We conducted reflective interviews with 37 UK autistic officers and staff and those with ADHD. Findings: Reflexive thematic analysis identified three themes: (1) identifying and requesting adjustments, (2) rank-based hierarchies and the role of gatekeepers and (3) navigating police process. Practical implications: Results suggest urgent need for training, streamlined adjustment processes, collaborative approaches to identifying needs and broader cultural transformation towards genuine neuro-inclusivity in policing organisations. Originality/value: Research with this population is rare but deserves attention. Policing is imbued with rank-based hierarchies, and findings showed how participants situated adjustments requests within this framing. Organisational features of policing are reflected in protocols and processes which were perceived as burdensome and created fears that their label may be weaponised against them.
- Open Access
- 16 October 2026
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 12 (6) , e265
Decades of national health strategy in England on intellectual disability and the drift from evidence-based practice
Summary: Over the past few decades, English health policy for people with intellectual disability has been shaped by legitimate concerns regarding care standards and the need for an inclusive health agenda. However, policies may be driven more by ideology than by empirical evidence. This editorial critically examines this premise using seven topical examples: (a) reduction of specialist in-patient beds, (b) mainstreaming healthcare, (c) specialist services challenges exemplified by children and forensic pathways for intellectual disability, (d) absence of application of outcome measures, (e) lack of a coordinated research agenda, (f) changes to mental health legislation and (g) the conflation of autism and intellectual disability. We highlight the risks of implementing large-scale system transformation without adequate evidence or evaluation of the impact of policy initiatives. We argue and provide recommendations for a rebalancing of policy towards evidence-based service design, investment in research and maintenance and development of specialist expertise.
- 16 October 2026
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 12 (6) , e265
Open AccessDecades of national health strategy in England on intellectual disability and the drift from evidence-based practice
Summary: Over the past few decades, English health policy for people with intellectual disability has been shaped by legitimate concerns regarding care standards and the need for an inclusive health agenda. However, policies may be driven more by ideology than by empirical evidence. This editorial critically examines this premise using seven topical examples: (a) reduction of specialist in-patient beds, (b) mainstreaming healthcare, (c) specialist services challenges exemplified by children and forensic pathways for intellectual disability, (d) absence of application of outcome measures, (e) lack of a coordinated research agenda, (f) changes to mental health legislation and (g) the conflation of autism and intellectual disability. We highlight the risks of implementing large-scale system transformation without adequate evidence or evaluation of the impact of policy initiatives. We argue and provide recommendations for a rebalancing of policy towards evidence-based service design, investment in research and maintenance and development of specialist expertise.
- 6 July 2026
- Published by Springer Nature in Journal of Autism and Developmental Disorders
Trends in Self-Reported Autism Among Adults in England: Analysis of a Repeated Cross-Sectional Patient Survey Series of 5,999,433 Adults
Whether autism is increasing is a subject of growing interest to researchers, health and social care professionals, policymakers, and the general public. We examined trends over time in the proportion of adults in England self-reporting as autistic, utilising data from an annual repeated cross-sectional survey series of adults registered with a General Practice in England. We report annual unweighted frequencies and weighted percentages (with 95% confidence intervals) for survey respondents self-reporting autism for 2018 to 2025, with equivalent data for self-reporting learning disability and a mental health condition. We additionally report the percentage change for 2019 to 2025, compared to a 2018 survey year baseline. Disaggregated data was reported according to age group, gender identity, and ethnicity. The weighted percentage of adults self-reporting as autistic has increased from 0.9% (95% CI 0.9-0.9) in 2018 to 2.6% (95% CI 2.5-2.7) in 2025, representing a 188.9% increase over a 7-year period. More modest percentage increases over this same time period were observed for learning disability (26.7%) and mental health condition (51.6%). The majority of the increase in adults self-reporting as autistic took place between the 2021 and 2025 survey years, over which time there was a 136.4% increase. There has been a substantial increase in adults self-reporting as autistic in England over a relatively short period of time, with an absence of similar increases in self-reporting as having a learning disability or a mental health condition. Further research is required to better understand the factors underpinning this change.
- 6 July 2026
- Published by Springer Nature in Journal of Autism and Developmental Disorders
Trends in Self-Reported Autism Among Adults in England: Analysis of a Repeated Cross-Sectional Patient Survey Series of 5,999,433 Adults
Whether autism is increasing is a subject of growing interest to researchers, health and social care professionals, policymakers, and the general public. We examined trends over time in the proportion of adults in England self-reporting as autistic, utilising data from an annual repeated cross-sectional survey series of adults registered with a General Practice in England. We report annual unweighted frequencies and weighted percentages (with 95% confidence intervals) for survey respondents self-reporting autism for 2018 to 2025, with equivalent data for self-reporting learning disability and a mental health condition. We additionally report the percentage change for 2019 to 2025, compared to a 2018 survey year baseline. Disaggregated data was reported according to age group, gender identity, and ethnicity. The weighted percentage of adults self-reporting as autistic has increased from 0.9% (95% CI 0.9-0.9) in 2018 to 2.6% (95% CI 2.5-2.7) in 2025, representing a 188.9% increase over a 7-year period. More modest percentage increases over this same time period were observed for learning disability (26.7%) and mental health condition (51.6%). The majority of the increase in adults self-reporting as autistic took place between the 2021 and 2025 survey years, over which time there was a 136.4% increase. There has been a substantial increase in adults self-reporting as autistic in England over a relatively short period of time, with an absence of similar increases in self-reporting as having a learning disability or a mental health condition. Further research is required to better understand the factors underpinning this change.
- Open Access
- 2 June 2026
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 12 (4) , e152
Prevalence and determinants of diabetes-related psychological distress in a tertiary care setting in Tamil Nadu, India: cross-sectional study – CORRIGENDUM
- 2 June 2026
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 12 (4) , e152
Open AccessPrevalence and determinants of diabetes-related psychological distress in a tertiary care setting in Tamil Nadu, India: cross-sectional study – CORRIGENDUM
- Open Access
- 27 April 2026
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 12 (3) , e119
Prevalence and determinants of diabetes-related psychological distress in a tertiary care setting in Tamil Nadu, India: cross-sectional study
Background: Diabetes distress, whereby people with diabetes experience distressing psychological symptoms associated with living with their condition, is an emerging problem in India. Diabetes distress leads to self-care deficits, suboptimal glycaemic control (which can lead to increasing risks of complications) and impaired quality of life. Aims: To determine the burden of diabetes distress and its associated factors in an Indian tertiary care centre in Trichy, Tamil Nadu, India, covering a population of 1.25 million. Method: This prospective observational study involved a structured questionnaire covering demographic and clinical details, which was given to patients. The Diabetes Distress Scale 17 (DDS-17) was used to assess diabetes distress levels. The DDS-17 also measures four subdomains: emotional burden, physician-related distress, regimen-related distress and diabetes-related interpersonal distress. Patients were divided into two groups based on their DDS-17 score: no diabetes distress (DDS-17 score t -tests were used, with P < 0.05 considered statistically significant. Results: Of 1019 respondents (mean age 56 years; 59.6% male, 40.4% female), diabetes distress was reported in 24.4% ( n = 249). Factors significantly associated with higher DDS-17 scores were younger age (10 years) ( P < 0.0001), and smoking and alcohol ( P < 0.05). Significant protective factors for diabetes distress included working, daily exercise, no comorbidities and medical insurance cover ( P < 0.05). Significant positive correlation between DDS-17 score and all four subdomains was observed ( P < 0.0001). Conclusions: Our findings highlight the need for routine psychological screening and holistic management strategies in diabetes care, to improve patient outcomes and quality of life.
- 27 April 2026
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 12 (3) , e119
Open AccessPrevalence and determinants of diabetes-related psychological distress in a tertiary care setting in Tamil Nadu, India: cross-sectional study
Background: Diabetes distress, whereby people with diabetes experience distressing psychological symptoms associated with living with their condition, is an emerging problem in India. Diabetes distress leads to self-care deficits, suboptimal glycaemic control (which can lead to increasing risks of complications) and impaired quality of life. Aims: To determine the burden of diabetes distress and its associated factors in an Indian tertiary care centre in Trichy, Tamil Nadu, India, covering a population of 1.25 million. Method: This prospective observational study involved a structured questionnaire covering demographic and clinical details, which was given to patients. The Diabetes Distress Scale 17 (DDS-17) was used to assess diabetes distress levels. The DDS-17 also measures four subdomains: emotional burden, physician-related distress, regimen-related distress and diabetes-related interpersonal distress. Patients were divided into two groups based on their DDS-17 score: no diabetes distress (DDS-17 score t -tests were used, with P < 0.05 considered statistically significant. Results: Of 1019 respondents (mean age 56 years; 59.6% male, 40.4% female), diabetes distress was reported in 24.4% ( n = 249). Factors significantly associated with higher DDS-17 scores were younger age (10 years) ( P < 0.0001), and smoking and alcohol ( P < 0.05). Significant protective factors for diabetes distress included working, daily exercise, no comorbidities and medical insurance cover ( P < 0.05). Significant positive correlation between DDS-17 score and all four subdomains was observed ( P < 0.0001). Conclusions: Our findings highlight the need for routine psychological screening and holistic management strategies in diabetes care, to improve patient outcomes and quality of life.
- Open Access
- 21 April 2026
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 12 (3) , e111
The impact paradox: mixed-methods evaluation of National Institute of Health and Care Research funding for intellectual disability research in the UK
Background: People with intellectual disability experience substantial health inequities, including higher multimorbidity, increased healthcare utilisation and markedly reduced life expectancy. High-quality research is essential to address these disparities. The National Institute for Health and Care Research (NIHR) funded Research Delivery Network provides the infrastructure/expertise/support needed to deliver NIHR-funded studies, and supports studies funded by a non-commercial/industry partner. However, the effectiveness of NIHR-funded studies versus those supported in driving impactful intellectual disability research remains unclear. Aims: To evaluate and compare the outcomes of NIHR-funded and supported intellectual disability research. Method: All NIHR studies (funded/supported) relating to intellectual disability (2010–2020) were identified through systematic register searches. Primary outcomes included publication rates and impact on local, national and international clinical guidelines. Data collection was supplemented with a questionnaire to chief investigators and literature searches. Quantitative analyses examined associations between funding status, study design, publication and guideline impact, whereas qualitative responses explored implementation challenges. Results: In total, 88 projects were identified, and 42% (37/88) were NIHR-funded. Overall, 81% of studies generated at least one publication and 28% informed clinical guidelines. NIHR funding was not significantly associated with publication or guideline impact. Randomised controlled trials (RCTs) were significantly more likely to be published and more likely to influence non-UK national and international guidelines than non-RCTs. The amount of funding showed no association with impact. Qualitative findings highlighted funding constraints, staff capacity and stakeholder engagement as key determinants of implementation. Conclusions: NIHR-funded intellectual disability research was no more likely than NIHR-supported studies to result in publications or guideline impact.
- 21 April 2026
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 12 (3) , e111
Open AccessThe impact paradox: mixed-methods evaluation of National Institute of Health and Care Research funding for intellectual disability research in the UK
Background: People with intellectual disability experience substantial health inequities, including higher multimorbidity, increased healthcare utilisation and markedly reduced life expectancy. High-quality research is essential to address these disparities. The National Institute for Health and Care Research (NIHR) funded Research Delivery Network provides the infrastructure/expertise/support needed to deliver NIHR-funded studies, and supports studies funded by a non-commercial/industry partner. However, the effectiveness of NIHR-funded studies versus those supported in driving impactful intellectual disability research remains unclear. Aims: To evaluate and compare the outcomes of NIHR-funded and supported intellectual disability research. Method: All NIHR studies (funded/supported) relating to intellectual disability (2010–2020) were identified through systematic register searches. Primary outcomes included publication rates and impact on local, national and international clinical guidelines. Data collection was supplemented with a questionnaire to chief investigators and literature searches. Quantitative analyses examined associations between funding status, study design, publication and guideline impact, whereas qualitative responses explored implementation challenges. Results: In total, 88 projects were identified, and 42% (37/88) were NIHR-funded. Overall, 81% of studies generated at least one publication and 28% informed clinical guidelines. NIHR funding was not significantly associated with publication or guideline impact. Randomised controlled trials (RCTs) were significantly more likely to be published and more likely to influence non-UK national and international guidelines than non-RCTs. The amount of funding showed no association with impact. Qualitative findings highlighted funding constraints, staff capacity and stakeholder engagement as key determinants of implementation. Conclusions: NIHR-funded intellectual disability research was no more likely than NIHR-supported studies to result in publications or guideline impact.
- Open Access
- 2 March 2026
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 12 (2) , e77
Antidepressant prescribing trends for adult patients in the UK and Ireland during the COVID-19 pandemic: systematic review
Background: Recent decades have seen a steady increase in antidepressant prescribing, but little is known about prescribing trends during and following the COVID-19 pandemic. Aims: This preregistered systematic review, following Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines, aimed to investigate antidepressant prescribing trends for adults in the UK and Republic of Ireland during and after the pandemic. It also compared prescriptions by drug and location. Method: We searched six databases: APA PsycInfo, CINAHL, MEDLINE, Scopus, medRxiv and Preprints.org. The review included primary research articles reporting trends in antidepressant prescriptions, including at least one time point after March 2020 in the UK and Republic of Ireland. This review has been preregistered on PROSPERO (ID: CRD42024498503). Results: We identified 7,320 studies, of which ten met the search criteria for the review. Studies were grouped on the basis of time period (2020: n = 5; 2021: n = 3; 2022: n = 2), location (England, Scotland, Northern Ireland, Republic of Ireland, UK) and drug type (serotonin–noradrenaline reuptake inhibitors, selective serotonin reuptake inhibitors, tricyclics, and others (e.g. monoamine oxidase inhibitors)). Most studies (eight of ten) demonstrated increased antidepressant prescribing over time. Two studies highlighted a decrease between March and May 2020. Demographic variables reflected higher rates of prescribing for women, and the modal group receiving antidepressants comprised middle-aged adults. Conclusions: The commonly reported increase in antidepressant prescribing corroborates pre-pandemic trends and may suggest further, increased demands for mental health support to meet the unique challenges of the pandemic. Future research is required to evaluate the appropriateness of treatment decisions and to explore psychosocial factors that influence individual prescribing choices.
- 2 March 2026
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 12 (2) , e77
Open AccessAntidepressant prescribing trends for adult patients in the UK and Ireland during the COVID-19 pandemic: systematic review
Background: Recent decades have seen a steady increase in antidepressant prescribing, but little is known about prescribing trends during and following the COVID-19 pandemic. Aims: This preregistered systematic review, following Preferred Reporting Items for Systematic reviews and Meta-Analyses guidelines, aimed to investigate antidepressant prescribing trends for adults in the UK and Republic of Ireland during and after the pandemic. It also compared prescriptions by drug and location. Method: We searched six databases: APA PsycInfo, CINAHL, MEDLINE, Scopus, medRxiv and Preprints.org. The review included primary research articles reporting trends in antidepressant prescriptions, including at least one time point after March 2020 in the UK and Republic of Ireland. This review has been preregistered on PROSPERO (ID: CRD42024498503). Results: We identified 7,320 studies, of which ten met the search criteria for the review. Studies were grouped on the basis of time period (2020: n = 5; 2021: n = 3; 2022: n = 2), location (England, Scotland, Northern Ireland, Republic of Ireland, UK) and drug type (serotonin–noradrenaline reuptake inhibitors, selective serotonin reuptake inhibitors, tricyclics, and others (e.g. monoamine oxidase inhibitors)). Most studies (eight of ten) demonstrated increased antidepressant prescribing over time. Two studies highlighted a decrease between March and May 2020. Demographic variables reflected higher rates of prescribing for women, and the modal group receiving antidepressants comprised middle-aged adults. Conclusions: The commonly reported increase in antidepressant prescribing corroborates pre-pandemic trends and may suggest further, increased demands for mental health support to meet the unique challenges of the pandemic. Future research is required to evaluate the appropriateness of treatment decisions and to explore psychosocial factors that influence individual prescribing choices.
- Open Access
- 23 January 2026
- Published by Center for Open Science in PsyArXiv
‘I'd think more about safety rather than efficacy’: A Qualitative Study of Antidepressant Prescribing and Decision Making in Primary Care in England
BackgroundConcerns around inappropriate antidepressant prescribing continue to be raised. To prevent avoidable harm to patients, including adverse effects and withdrawal effects, it is important to understand potential overprescribing of antidepressants. This study aims to explore how primary care prescribers rationalise antidepressant prescribing and deprescribing decisions, and which contextual factors influence these decisions. MethodWe interviewed 16 primary care professionals, general practitioners (GPs) and mental health practitioners, across England. Semi-structured interviews consisted of discussing prescribing and deprescribing vignettes, followed by questions exploring participants approaches to antidepressant decision making. Reflexive thematic analysis was used to analyse the data. ResultsFour main themes emerged around antidepressant medicines optimisation: patient characteristics, illness factors, prescriber characteristics, and healthcare service factors. Patient characteristics encompassed aspects of the patient, their life and ideas that could contribute to prescribing choices. Illness factors included consideration of depression symptoms, associated symptom risks and previous treatment experiences. Prescriber characteristics involved expertise, guideline adherence, risk aversion and decision fatigue arising from prescribing. Healthcare service factors captured constraints of the services format and availability of alternative treatments.ConclusionOur findings suggest that prescribing decisions are impacted by a combination of psychosocial and environmental factors. Decision biases like risk aversion and decision fatigue can also impact prescribing practice. Health service constraints were perceived as limiting decision freedom through misaligned demand for and availability of non-pharmacological treatments, and insufficient decision support for deprescribing. Future research is required to establish patient and public perspectives and preferences for treatment.
- 23 January 2026
- Published by Center for Open Science in PsyArXiv
Open Access‘I'd think more about safety rather than efficacy’: A Qualitative Study of Antidepressant Prescribing and Decision Making in Primary Care in England
BackgroundConcerns around inappropriate antidepressant prescribing continue to be raised. To prevent avoidable harm to patients, including adverse effects and withdrawal effects, it is important to understand potential overprescribing of antidepressants. This study aims to explore how primary care prescribers rationalise antidepressant prescribing and deprescribing decisions, and which contextual factors influence these decisions. MethodWe interviewed 16 primary care professionals, general practitioners (GPs) and mental health practitioners, across England. Semi-structured interviews consisted of discussing prescribing and deprescribing vignettes, followed by questions exploring participants approaches to antidepressant decision making. Reflexive thematic analysis was used to analyse the data. ResultsFour main themes emerged around antidepressant medicines optimisation: patient characteristics, illness factors, prescriber characteristics, and healthcare service factors. Patient characteristics encompassed aspects of the patient, their life and ideas that could contribute to prescribing choices. Illness factors included consideration of depression symptoms, associated symptom risks and previous treatment experiences. Prescriber characteristics involved expertise, guideline adherence, risk aversion and decision fatigue arising from prescribing. Healthcare service factors captured constraints of the services format and availability of alternative treatments.ConclusionOur findings suggest that prescribing decisions are impacted by a combination of psychosocial and environmental factors. Decision biases like risk aversion and decision fatigue can also impact prescribing practice. Health service constraints were perceived as limiting decision freedom through misaligned demand for and availability of non-pharmacological treatments, and insufficient decision support for deprescribing. Future research is required to establish patient and public perspectives and preferences for treatment.
- Open Access
- 23 October 2025
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 11 (6) , e249
Psychiatrists and non-psychiatrists’ attitudes to psychotropic optimisation for people with intellectual disabilities and/or autism: cross-sectional comparison study
Background: Off-licence psychotropic use in people with intellectual disability and/or autism, in the absence of psychiatric illness, is a major public health concern in England. Aims: To ascertain and compare views of psychiatrists and non-psychiatrists working with people with intellectual disability and/or autism on psychotropic medication optimisation for this population. Method: A cross-sectional survey of 13 questions was disseminated online among psychiatrists and other health professionals working with people with intellectual disability and/or autism across England, using a non-discriminatory exponential snowballing technique leading to non-probability sampling. The questionnaire covered demographic characteristics, perceived barriers/benefits of psychotropic optimisation (including ethnicity) and views on implementation of a national medicine optimisation programme. Quantitative analysis used chi-squared, Mann–Whitney and unpaired t -tests, with significance taken as P < 0.05. Thematic analysis of free-text responses was undertaken with Braun and Clarke’s methodology. Results: Of 219 respondents, significant differences in attitudes to most issues emerged between psychiatrists ( n = 66) and non-psychiatrists ( n = 149). Psychiatrists had less optimism of a successful national medication optimisation programme if commissioned, or achieving 50% reduction in psychotropic overprescribing and inappropriate psychotropic prescribing generally. Perceived barriers to reducing overmedication differed significantly between the psychiatrists and non-psychiatrists, Thematic analysis identified five themes (system issues, resources, medication challenges, family and carers, and training and alternatives/structure). Conclusions: This is the first study to highlight important differences between psychiatrists and non-psychiatrists’ attitudes to psychotropic optimisation despite respondents overall being broadly supportive of its need. A major finding is the hitherto unquantified concerns of patient ethnicity and its impact on psychotropic optimisation principles.
- 23 October 2025
- Published by Royal College of Psychiatrists in BJPsych Open
- Vol. 11 (6) , e249
Open AccessPsychiatrists and non-psychiatrists’ attitudes to psychotropic optimisation for people with intellectual disabilities and/or autism: cross-sectional comparison study
Background: Off-licence psychotropic use in people with intellectual disability and/or autism, in the absence of psychiatric illness, is a major public health concern in England. Aims: To ascertain and compare views of psychiatrists and non-psychiatrists working with people with intellectual disability and/or autism on psychotropic medication optimisation for this population. Method: A cross-sectional survey of 13 questions was disseminated online among psychiatrists and other health professionals working with people with intellectual disability and/or autism across England, using a non-discriminatory exponential snowballing technique leading to non-probability sampling. The questionnaire covered demographic characteristics, perceived barriers/benefits of psychotropic optimisation (including ethnicity) and views on implementation of a national medicine optimisation programme. Quantitative analysis used chi-squared, Mann–Whitney and unpaired t -tests, with significance taken as P < 0.05. Thematic analysis of free-text responses was undertaken with Braun and Clarke’s methodology. Results: Of 219 respondents, significant differences in attitudes to most issues emerged between psychiatrists ( n = 66) and non-psychiatrists ( n = 149). Psychiatrists had less optimism of a successful national medication optimisation programme if commissioned, or achieving 50% reduction in psychotropic overprescribing and inappropriate psychotropic prescribing generally. Perceived barriers to reducing overmedication differed significantly between the psychiatrists and non-psychiatrists, Thematic analysis identified five themes (system issues, resources, medication challenges, family and carers, and training and alternatives/structure). Conclusions: This is the first study to highlight important differences between psychiatrists and non-psychiatrists’ attitudes to psychotropic optimisation despite respondents overall being broadly supportive of its need. A major finding is the hitherto unquantified concerns of patient ethnicity and its impact on psychotropic optimisation principles.